The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)
The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)
The medical device company sprouts SaaS-like metrics; 30%+ growth, 80% recurring revenues, 80%+ gross margin and it's profitable and cash flow positive..
The medical device company sprouts SaaS-like metrics; 30%+ growth, 80% recurring revenues, 80%+ gross margin and it's profitable and cash flow positive.
1. zyxi (26 dec 2018)
Zynex NexWave Prescription Pain Management Tens Unit
The Zynex Party Has Much Further To Go (NASDAQ:ZYXI)
Zynex Medical Non-Invasive Pain Management & Devices
Why Stars Group, Sibanye Gold, and Zynex Jumped Today
Zynex: A Fact Finding Mission (NASDAQ:ZYXI)
Zynex Medical Jobs & Careers, Hiring Nationwide
Zynex Inc (ZYXI) Q3 2023 Earnings: Revenue Up 20% to $49.9 Million, EPS at $0.10
.jpg)
Zynex Inc. (NASDAQ: ZYXI) Shows Promising Potential, Forecasting a Potential Surge to $28.00 in the Next Year - AdvisersMedia - Market and Business News
Zynex (NASDAQ:ZYXI) shareholders have earned a 27% CAGR over the last five years
ZYXI Stock Price and Chart — NASDAQ:ZYXI — TradingView
